Stanford Researchers Develop Skin-Based Vaccine Using Harmless Bacteria

Stanford scientists have created a groundbreaking method of delivering vaccines by turning a common skin bacterium, Staphylococcus epidermidis, into a living vaccine that can be applied as a cream.

Stanford Researchers Develop Skin-Based Vaccine Using Harmless Bacteria. Photo: tasnimnews.com

The research was led by bioengineering professor Michael Fischbach and postdoctoral scholar Djenet Bousbaine.

Fischbach explained the appeal of a needle-free alternative: “We all hate needles — everybody does. I haven’t found a single person who doesn’t like the idea that it’s possible to replace a shot with a cream.”

The bacterium, which naturally resides on human skin, triggered a robust immune response in both mice and human studies. “It’s as if the mice had been vaccinated,” Fischbach said.

In their experiments, researchers swabbed mice with S. epidermidis, prompting the production of high antibody levels. The team identified a protein, Aap, as the key trigger for this immune response.

Fischbach’s team bioengineered S. epidermidis to display harmless fragments of tetanus and diphtheria toxins within Aap’s structure. The modified bacteria successfully induced strong antibody production in mice, protecting them from lethal toxin doses.

The approach also produced antibodies targeting mucosal surfaces in the nostrils, which Fischbach noted could help stop respiratory pathogens like flu and COVID-19 before they infect the body.

“Normal vaccines go to work only once the pathogen gets into the blood,” Fischbach said. “It would be much better to stop it from getting in the first place.”

The team further tested a chemically modified version of the bacteria, enhancing its ability to generate protective antibodies. Fischbach said their next steps include trials on monkeys, with human clinical trials anticipated in two to three years.

“We think this will work for viruses, bacteria, fungi, and one-celled parasites,” Fischbach said. “We expect that you wouldn’t experience any inflammation at all.”

The research was supported by collaborations with the University of California, Davis, and several US National Institutes of Health agencies. (Tasnim News Agency)

YOU MAY ALSO LIKE

Long-term exposure to air pollution linked to blood clots in veins

A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause serious complications, even death.

Research reveals new insights about how 'bad' cholesterol works in the body

Findings could pave the way for more personalized treatments for cardiovascular disease.

Test for early detection of lung cancer

Cambridge scientists have developed a urine test for early detection of lung cancer. The test, the first of its kind, detects ‘zombie’ cells that could indicate the first signs of the disease.

Obesity May Cause Men to Lose Memory A Decade Earlier than Women

Men with obesity face an earlier onset of cognitive decline compared to women, a study by Imperial College London reveals, underscoring the role of cardiovascular health in dementia risk.

Therapy, Rehabilitation Show Promise for Long COVID Relief

Talking therapies and physical rehabilitation may offer effective treatment for long COVID symptoms, according to a groundbreaking Canadian study.

Time alone heightens ‘threat alert’ in teenagers – even when connecting online

Scientists say the findings might shed light on the link between loneliness and mental health conditions such as anxiety disorders, which are on the rise in young people.